S. Gail Eckhardt

7.3k citations
105 papers · 5.3k · 2 hit papers · h-index 36

Impact in

  • Oncology top 1%
    • Colorectal Cancer Treatments and Studies
    • Peptidase Inhibition and Analysis
    • Pancreatic and Hepatic Oncology Research
    • Cancer-related Molecular Pathways
    • Cancer Immunotherapy and Biomarkers
    • Protease and Inhibitor Mechanisms

Papers in

    • Colorectal Cancer Treatments and Studies 21
    • Cancer Treatment and Pharmacology 15
    • HER2/EGFR in Cancer Research 10
    • Cancer Immunotherapy and Biomarkers 10
    • PI3K/AKT/mTOR signaling in cancer 8

S. Gail Eckhardt

105 papers receiving 5.2k citations

S. Gail Eckhardt's Hit Papers

Sunitinib: From Rational Design to Clinical Efficacy 2007 · 718 citations
7180+8+16Years since publication200400600

Peers

S. Gail Eckhardt
Comparison fields: 5 of 123
  • Oncology 2.5k
  • Cancer Research 1.2k
  • Molecular Biology 2.6k
  • Pulmonary and Respiratory Medicine 1.1k
  • Hepatology 250
Replace Devalingam Mahalingam with:
Devalingam Mahalingam United States
Shivaani Kummar United States
Anderson J. Ryan United Kingdom
Miguel A. Villalona‐Calero United States
Kenji Kawada Japan
Marcella Mottolese Italy
Carolyn D. Britten United States
Ferry A.L.M. Eskens Netherlands
Tona M. Gilmer United States
Suzanne F. Jones United States
S. Gail Eckhardt relative to Devalingam Mahalingam United States Devalingam Mahalingam's profile →
Citations per field
00.5×1.6×
Devalingam Mahalingam · 1×
Citations per year

Countries citing papers authored by S. Gail Eckhardt

Since Specialization
Citations

This map shows the geographic impact of S. Gail Eckhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Gail Eckhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Gail Eckhardt more than expected).

Fields of papers citing papers by S. Gail Eckhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Gail Eckhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Gail Eckhardt. The network helps show where S. Gail Eckhardt may publish in the future.

Co-authors

The 25 scholars most cited alongside S. Gail Eckhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S. Gail Eckhardt Line = papers co-authored together S. Gail Eckhardt links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sunitinib: From Rational Design to Clinical Efficacy
Hit paper breakdown →
2007718
2
Development of Matrix Metalloproteinase Inhibitors in Cancer Therapy
Hit paper breakdown →
2001655
3 2008340
4 2006227
5 2001181
6 1999158
7 1999141
8 2008140
9 2019135
10 2010133
11 2019127
12 1998114
13 1991111
14 200598
15 200998
16
A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077.
200088
17 201586
18 201778
19 200677
20
NMR-based metabolomics: translational application and treatment of cancer.
200769

About S. Gail Eckhardt

S. Gail Eckhardt is a scholar working on Oncology, Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine and Cell Biology, having authored 105 papers that have together received 5.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (21 papers), Cancer Treatment and Pharmacology (15 papers), Cancer Genomics and Diagnostics (14 papers), Lung Cancer Treatments and Mutations (12 papers), HER2/EGFR in Cancer Research (10 papers), Cancer Immunotherapy and Biomarkers (10 papers), Microtubule and mitosis dynamics (9 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (1.2k citations), Molecular Biology (2.6k citations), Pulmonary and Respiratory Medicine (1.1k citations) and Hepatology (250 citations). S. Gail Eckhardt has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Laura Q.M. Chow, Manuel Hidalgo, Avi Ashkenazi, Pamela M. Holland, Todd M. Pitts, Wells A. Messersmith, John J. Tentler, Natalie J. Serkova, Lia Gore and A. McLachlan. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Molecular Cancer Therapeutics, Cancer Chemotherapy and Pharmacology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact